AI-generated summary
In this mouse study, isoproterenol was used to induce heart failure, and the authors report that photobiomodulation was associated with reduced cardiac dysfunction, fibrosis and cardiomyocyte apoptosis. They attribute these effects to changes in the TGF-β/Smad7 and PI3K/AKT pathways. The abstract describes an animal model and does not report human outcomes.
- Participants
- 48
- Who or what was studied
- Adult male C57BL/6 mice with isoproterenol-induced heart failure
- Limits stated in the abstract
- The study was conducted in mice, and the abstract does not report wavelengths, dosing or human data.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photobiomodulation therapy, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.